297 related articles for article (PubMed ID: 27977667)
1. Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines.
Subramanian R; Graham AL; Grenfell BT; Arinaminpathy N
PLoS Comput Biol; 2016 Dec; 12(12):e1005204. PubMed ID: 27977667
[TBL] [Abstract][Full Text] [Related]
2. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
[TBL] [Abstract][Full Text] [Related]
3. Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza.
Arinaminpathy N; Ratmann O; Koelle K; Epstein SL; Price GE; Viboud C; Miller MA; Grenfell BT
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3173-7. PubMed ID: 22323589
[TBL] [Abstract][Full Text] [Related]
4. Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.
Bolton KJ; McCaw JM; Brown L; Jackson D; Kedzierska K; McVernon J
PLoS One; 2015; 10(3):e0120138. PubMed ID: 25811654
[TBL] [Abstract][Full Text] [Related]
5. Advances in the development of universal influenza vaccines.
Gilbert SC
Influenza Other Respir Viruses; 2013 Sep; 7(5):750-8. PubMed ID: 22998622
[TBL] [Abstract][Full Text] [Related]
6. The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.
Zhang XS; Pebody R; De Angelis D; White PJ; Charlett A; McCauley JW
PLoS One; 2014; 9(12):e114637. PubMed ID: 25494180
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
8. Current challenges: from the path of "original antigenic sin" towards the development of universal flu vaccines.
Biswas A; Chakrabarti AK; Dutta S
Int Rev Immunol; 2020; 39(1):21-36. PubMed ID: 31707873
[TBL] [Abstract][Full Text] [Related]
9. Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine.
Viboud C; Gostic K; Nelson MI; Price GE; Perofsky A; Sun K; Sequeira Trovão N; Cowling BJ; Epstein SL; Spiro DJ
PLoS Pathog; 2020 Sep; 16(9):e1008583. PubMed ID: 32970783
[TBL] [Abstract][Full Text] [Related]
10. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
11. Population implications of the deployment of novel universal vaccines against epidemic and pandemic influenza.
Arinaminpathy N; Riley S; Barclay WS; Saad-Roy C; Grenfell B
J R Soc Interface; 2020 Mar; 17(164):20190879. PubMed ID: 32126190
[TBL] [Abstract][Full Text] [Related]
12. Universal influenza vaccines: a realistic option?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
[TBL] [Abstract][Full Text] [Related]
13. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.
Bragstad K; Martel CJ; Thomsen JS; Jensen KL; Nielsen LP; Aasted B; Fomsgaard A
Influenza Other Respir Viruses; 2011 Jan; 5(1):13-23. PubMed ID: 21138536
[TBL] [Abstract][Full Text] [Related]
14. Co-circulation of influenza A virus strains and emergence of pandemic via reassortment: the role of cross-immunity.
Zhang XS; De Angelis D; White PJ; Charlett A; Pebody RG; McCauley J
Epidemics; 2013 Mar; 5(1):20-33. PubMed ID: 23438428
[TBL] [Abstract][Full Text] [Related]
15. Vaccines for seasonal and pandemic influenza.
Nichol KL; Treanor JJ
J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
[TBL] [Abstract][Full Text] [Related]
16. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactive humoral responses to influenza and their implications for a universal vaccine.
Chiu C; Wrammert J; Li GM; McCausland M; Wilson PC; Ahmed R
Ann N Y Acad Sci; 2013 Apr; 1283():13-21. PubMed ID: 23405860
[TBL] [Abstract][Full Text] [Related]
18. Seasonal influenza vaccination and technologies.
Nafziger AN; Pratt DS
J Clin Pharmacol; 2014 Jul; 54(7):719-31. PubMed ID: 24691877
[TBL] [Abstract][Full Text] [Related]
19. Towards the knowledge-based design of universal influenza epitope ensemble vaccines.
Sheikh QM; Gatherer D; Reche PA; Flower DR
Bioinformatics; 2016 Nov; 32(21):3233-3239. PubMed ID: 27402904
[TBL] [Abstract][Full Text] [Related]
20. Dynamic Perspectives on the Search for a Universal Influenza Vaccine.
Saad-Roy CM; McDermott AB; Grenfell BT
J Infect Dis; 2019 Apr; 219(Suppl_1):S46-S56. PubMed ID: 30715467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
